Class I — UrgentReported 2024-12-11 ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com
Recalled by Boulla LLC
Reason for Recall
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Advertisement
Recall NumberD-0086-2025ClassificationClass IStatusOngoingCategorydrugInitiated2024-11-04Reported2024-12-11DistributionNationwide within the United StatesCode InfoLot #: YZM240406, Exp: 04/05/2027Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.